The different role of sex hormones on female cardiovascular physiology and function: Not only oestrogens

European Journal of Clinical Investigation

Volumn 45, Issue 6, 2015, Pages 634-645

  Salerni, Sara ^a   Di Francescomarino, Samanta ^a   Cadeddu, Christian ^b   Acquistapace, Flavio ^c   Maffei, Silvia ^d   Gallina, Sabina ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c Cardiologic Medical Center Manno   (Switzerland)

^d INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

Androgen; Cardiovascular remodelling; Oestrogen; Progesterone; Sex hormones

Indexed keywords

ANDROGEN; ESTROGEN; ION CHANNEL; PROGESTERONE; CALCIUM CHANNEL; SEX HORMONE;

ANDROGEN SYNTHESIS; AUTONOMIC NERVOUS SYSTEM; CARDIOVASCULAR FUNCTION; CLIMACTERIUM; DAILY LIFE ACTIVITY; ESTROGEN SYNTHESIS; EXCITATION; FEMALE; GENOMICS; HEART PERFORMANCE; HUMAN; MODULATION; MYOCARDIAL REMODELLING; NONHUMAN; PRIORITY JOURNAL; PROGESTERONE SYNTHESIS; REVIEW; SEX DIFFERENCE; ANIMAL; EXCITATION CONTRACTION COUPLING; FORECASTING; HEART; MENOPAUSE; PHYSIOLOGY; SECRETION (PROCESS); SIGNAL TRANSDUCTION;

ANDROGENS; ANIMALS; AUTONOMIC NERVOUS SYSTEM; CALCIUM CHANNELS; CARDIOVASCULAR PHYSIOLOGICAL PHENOMENA; ESTROGENS; EXCITATION CONTRACTION COUPLING; FEMALE; FORECASTING; GONADAL STEROID HORMONES; HEART; HUMANS; MENOPAUSE; PROGESTERONE; SIGNAL TRANSDUCTION;

EID: 84929502845     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12447     Document Type: Review

References (76)

1. Piro M, Della Bona R, Abbate A, Biasucci LM, Crea F. Sex-related differences in myocardial remodeling. J Am Coll Cardiol 2010;55:1057-65.
2. Dent MR, Tappia PS, Dhalla NS. Gender differences in cardiac dysfunction and remodeling due to volume overload. J Card Fail 2011;16:439-49.
3. Villar AV, Llano M, Cobo M et al. Gender differences of echocardio-graphic and gene expression patterns in human pressure overload left ventricular hypertrophy. J Mol Cell Cardiol 2009;46:526-35.
4. Guerra S, Leri A, Wang X et al. Myocyte death in the failing human heart is gender dependent. Circ Res 1999;85:856-66.
5. Dart AM, Du XJ, Kingwell BA. Gender, sex hormones and autonomic nervous control of the cardiovascular system. Cardiovasc Res 2002;53:678-87.
6. Parks RJ, Howlett SE. Sex differences in mechanisms of cardiac excitation-contraction coupling. Pflugers Arch 2013;465:747-63.
7. Sedlak T, Shufelt C, Iribarren C, Merz CN. Sex hormones and the QT interval: a review. J Womens Health 2012;21:933-41.
8. Murphy E. Estrogen signaling and cardiovascular disease. Circ Res 2011;109:687-96.
9. Harada N. Aromatase and intracrinology of estrogen in hormone-dependent tumors. Oncology 1999;57(Suppl 2):7-16.
10. Nakamura Y, Suzuki T, Sasano H. Estrogen actions and in situ synthesis in human vascular smooth muscle cells and their correlation with atherosclerosis. J Steroid Biochem Mol Biol 2005;93:263-8.
11. Meyer MR, Barton M. ERalpha, ERbeta, and gpER: novel aspects of oestrogen receptor signalling in atherosclerosis. Cardiovasc Res 2009;83:605-10.
12. Mendelsohn ME. Genomic and nongenomic effects of estrogen in the vasculature. Am J Cardiol 2002;90:3F-6F.
13. Gronemeyer H, Gustafsson JA, Laudet V. Principles for modulation of the nuclear receptor superfamily. Nat Rev Drug Discovery 2004;3:950-64.
14. Rubanyi GM, Kauser K, Johns A. Role of estrogen receptors in the vascular system. Vascul Pharmacol 2002;38:81-8.
15. Meyer MR, Prossnitz ER, Barton M. The G protein-coupled estrogen receptor GPER/GPR30 as a regulator of cardiovascular function. Vascul Pharmacol 2011;55:17-25.
16. Guo X, Razandi M, Pedram A, Kassab G, Levin ER. Estrogen induces vascular wall dilation: mediation through kinase signaling to nitric oxide and estrogen receptors alpha and beta. J Biol Chem 2005;280:19704-10.
17. Simoncini T, Mannella P, Genazzani AR. Rapid estrogen actions in the cardiovascular system. Ann N Y Acad Sci 2006;1089:424-30.
18. Fu XD, Simoncini T. Non-genomic sex steroid actions in the vascular system. Semin Reprod Med 2007;25:178-86.
19. Vassalle C, Simoncini T, Chedraui P, Perez-Lopez FR. Why sex matters: the biological mechanisms of cardiovascular disease. Gynecol Endocrinol 2012;28:746-51.
20. Mercuro G, Zoncu S, Pilia I, Lao A, Melis GB, Cherchi A. Effects of acute administration of transdermal estrogen on postmenopausal women with systemic hypertension. Am J Cardiol 1997;80:652-5.
21. Volterrani M, Rosano G, Coats A, Beale C, Collins P. Estrogen acutely increases peripheral blood flow in postmenopausal women. Am J Med 1995;99:119-22.
22. Magness RR, Rosenfeld CR. Local and systemic estradiol-17 beta: effects on uterine and systemic vasodilation. Am J Physiol 1989;256:E536-42.
23. Higashi Y, Sanada M, Sasaki S et al. Effect of estrogen replacement therapy on endothelial function in peripheral resistance arteries in normotensive and hypertensive postmenopausal women. Hypertension 2001;37:651-7.
24. Dubey RK, Gillespie DG, Jackson EK, Keller PJ. 17Beta-estradiol, its metabolites, and progesterone inhibit cardiac fibroblast growth. Hypertension 1998;31:522-8.
25. Abbate A, Biondi-Zoccai GG, Baldi A. Pathophysiologic role of myocardial apoptosis in post-infarction left ventricular remodeling. J Cell Physiol 2002;193:145-53.
26. Vanhaesebroeck B, Alessi DR. The PI3K-PDK1 connection: more than just a road to PKB. Biochem J 2000;346(Pt 3):561-76.
27. Grohe C, Kahlert S, Lobbert K et al. Cardiac myocytes and fibroblasts contain functional estrogen receptors. FEBS Lett 1997;416:107-12.
28. Kararigas G, Fliegner D, Gustafsson JA, Regitz-Zagrosek V. Role of the estrogen/estrogen-receptor-beta axis in the genomic response to pressure overload-induced hypertrophy. Physiol Genomics 2011;43:438-46.
29. Pedram A, Razandi M, Aitkenhead M, Levin ER. Estrogen inhibits cardiomyocyte hypertrophy in vitro. Antagonism of calcineurin-related hypertrophy through induction of MCIP1. J Biol Chem 2005;280:26339-48.
30. Wilkins BJ, Dai YS, Bueno OF et al. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy. Circ Res 2004;94:110-8.
31. Deschamps AM, Murphy E, Sun J. Estrogen receptor activation and cardioprotection in ischemia reperfusion injury. Trends Cardiovasc Med 2010;20:73-8.
32. Bae S, Zhang L. Gender differences in cardioprotection against ischemia/reperfusion injury in adult rat hearts: focus on Akt and protein kinase C signaling. J Pharmacol Exp Ther 2005;315:1125-35.
33. Mohamed MK, El-Mas MM, Abdel-Rahman AA. Estrogen enhancement of baroreflex sensitivity is centrally mediated. Am J Physiol 1999;276:R1030-7.
34. Saleh MC, Connell BJ, Saleh TM. Medullary and intrathecal injections of 17beta-estradiol in male rats. Brain Res 2000;867:200-9.
35. Olsen KL, Edwards E, Schechter N, Whalen RE. Muscarinic receptors in preoptic area and hypothalamus: effects of cyclicity, sex and estrogen treatment. Brain Res 1988;448:223-9.
36. Ullrich ND, Krust A, Collins P, MacLeod KT. Genomic deletion of estrogen receptors ERalpha and ERbeta does not alter estrogen-mediated inhibition of Ca2+ influx and contraction in murine cardiomyocytes. Am J Physiol Heart Circ Physiol 2008;294:H2421-7.
37. Wattanapermpool J, Riabroy T, Preawnim S. Estrogen supplement prevents the calcium hypersensitivity of cardiac myofilaments in ovariectomized rats. Life Sci 2000;66:533-43.
38. Saito T, Ciobotaru A, Bopassa JC, Toro L, Stefani E, Eghbali M. Estrogen contributes to gender differences in mouse ventricular repolarization. Circ Res 2009;105:343-52.
39. Furukawa T, Kurokawa J. Regulation of cardiac ion channels via non-genomic action of sex steroid hormones: implication for the gender difference in cardiac arrhythmias. Pharmacol Ther 2007;115:106-15.
40. Donaldson LE, Basset JM, Thorburn GD. Peripheral plasma progesterone concentration of cows during puberty, moestrous cycles, pregnancy and lactation, and the effects of under-nutrition or exogenous oxytocin on progesterone concentration. J Endocrinol 1970;48:599-614.
41. Karas RH, van Eickels M, Lydon JP et al. A complex role for the progesterone receptor in the response to vascular injury. J Clin Investig 2001;108:611-8.
42. Barbagallo M, Dominguez LJ, Licata G et al. Vascular effects of progesterone: role of cellular calcium regulation. Hypertension 2001;37:142-7.
43. Orshal JM, Khalil AR. Gender, sex hormones, and vascular tone. Am J Physiol Regul Integr Comp Physiol 2004;286:R233-49.
44. Rossi P, Frances Y, Kingwell BA, Ahimastos AA. Gender differences in artery wall biomechanical properties throughout life. J Hypertens 2011;29:1023-33.
45. Cheng J, Ma X, Zhang J, Su D. Diverse modulating effects of estradiol and progesterone on the monophasic action potential duration in Langendorff-perfused female rabbit hearts. Fundam Clin Pharmacol 2012;26:219-26.
46. Nakamura H, Kurokawa J, Bai CX et al. Progesterone regulates cardiac repolarization through a nongenomic pathway: an in vitro patch-clamp and computational modeling study. Circulation 2007;116:2913-22.
47. Kurokawa J, Furukawa T. Non-genomic action of sex steroid hormones and cardiac repolarization. Biol Pharm Bull 2013;36:8-12.
48. Hiort O. Androgens and puberty. Best Pract Res Clin Endocrinol Metab 2002;16:31-41.
49. Wilson C, Maass R, Estrada M. Cardiovascular effects of androgens. In: Akin DF, editor Basic and Clinical Endocrinology Up-to-Date: In Tech. 2011. Available from: http://www.intechopen.com/books/basic-and-clinical-endocrinology-up-to-date/cardiovascular-effects-of-androgens. Accessed on 17 November 2011.
50. Horstman AM, Dillon EL, Urban RJ, Sheffield-Moore M. The role of androgens and estrogens on healthy aging and longevity. J Gerontol A Biol Sci Med Sci 2012;67:1140-52.
51. Sowers MF, Zheng H, McConnell D, Nan B, Karvonen-Gutierrez CA, Randolph JF Jr. Testosterone, sex hormone-binding globulin and free androgen index among adult women: chronological and ovarian aging. Hum Reprod 2009;24:2276-85.
52. Lasley BL, Crawford S, McConnell DS. Adrenal androgens and the menopausal transition. Obstet Gynecol Clin North Am 2011;38:467-75.
53. Yasui T, Matsui S, Tani A, Kunimi K, Yamamoto S, Irahara M. Androgen in postmenopausal women. J Med Invest 2012;59:12-27.
54. Cao Y, Zhang S, Zou S, Xia X. The relationship between endogenous androgens and body fat distribution in early and late postmenopausal women. PLoS One 2013;8:e58448.
55. Lerchbaum E, Schwetz V, Rabe T, Giuliani A, Obermayer-Pietsch B. Hyperandrogenemia in polycystic ovary syndrome: exploration of the role of free testosterone and androstenedione in metabolic phenotype. PLoS One 2014;9:e108263.
56. Beesley RD, Palmer BM, Casson PR, Toth MJ. Effects of testosterone on cardiomyocyte calcium homeostasis and contractile function in female rats. Exp Physiol 2013;98:161-71.
57. Casson PR, Toth MJ, Johnson JV, Stanczyk FZ, Casey CL, Dixon ME. Correlation of serum androgens with anthropometric and metabolic indices in healthy, nonobese postmenopausal women. J Clin Endocrinol Metab 2010;95:4276-82.
58. Morley JE, Perry HM III. Androgens and women at the menopause and beyond. J Gerontol A Biol Sci Med Sci 2003;58:M409-16.
59. Iellamo F, Volterrani M, Caminiti G et al. Testosterone therapy in women with chronic heart failure: a pilot double-blind, randomized, placebo-controlled study. J Am Coll Cardiol 2010;56:1310-6.
60. Liu A, Gao L, Kang S et al. Testosterone enhances estradiol's cardioprotection in ovariectomized rats. J Endocrinol 2012;212:61-9.
61. Campelo AE, Cutini PH, Massheimer VL. Cellular actions of testosterone in vascular cells: mechanism independent of aromatization to estradiol. Steroids 2012;77:1033-40.
62. Herring MJ, Oskui PM, Hale SL, Kloner RA. Testosterone and the cardiovascular system: a comprehensive review of the basic science literature. J Am Heart Assoc 2013;2:e000271.
63. Chinnathambi V, Yallampalli C, Sathishkumar K. Prenatal testosterone induces sex-specific dysfunction in endothelium-dependent relaxation pathways in adult male and female rats. Biol Reprod 2013;89:97.
64. Worboys S, Kotsopoulos D, Teede H, McGrath B, Davis SR. Evidence that parenteral testosterone therapy may improve endothelium-dependent and -independent vasodilation in postmenopausal women already receiving estrogen. J Clin Endocrinol Metab 2001;86:158-61.
65. Zaugg M, Jamali NZ, Lucchinetti E et al. Anabolic-androgenic steroids induce apoptotic cell death in adult rat ventricular myocytes. J Cell Physiol 2001;187:90-5.
66. Dobaczewski M, Chen W, Frangogiannis NG. Transforming growth factor (TGF)-beta signaling in cardiac remodeling. J Mol Cell Cardiol 2011;51:600-6.
67. Hofmann U, Bonz A, Frantz S et al. A collagen alpha2(I) mutation impairs healing after experimental myocardial infarction. Am J Pathol 2012;180:113-22.
68. Fischer M, Baessler A, Schunkert H. Renin angiotensin system and gender differences in the cardiovascular system. Cardiovasc Res 2002;53:672-7.
69. Ellison KE, Ingelfinger JR, Pivor M, Dzau VJ. Androgen regulation of rat renal angiotensinogen messenger RNA expression. J Clin Investig 1989;83:1941-5.
70. Frantz S, Hu K, Widder J et al. Detrimental effects of testosterone on post-myocardial infarction remodelling in female rats. J Physiol Pharmacol 2007;58:717-27.
71. Cavasin MA, Sankey SS, Yu AL, Menon S, Yang XP. Estrogen and testosterone have opposing effects on chronic cardiac remodeling and function in mice with myocardial infarction. Am J Physiol Heart Circ Physiol 2003;284:H1560-9.
72. Er F, Michels G, Brandt MC et al. Impact of testosterone on cardiac L-type calcium channels and Ca2+ sparks: acute actions antagonize chronic effects. Cell Calcium 2007;41:467-77.
73. Golden KL, Marsh JD, Jiang Y, Brown T, Moulden J. Gonadectomy of adult male rats reduces contractility of isolated cardiac myocytes. Am J Physiol Endocrinol Metab 2003;285:E449-53.
74. Bai CX, Kurokawa J, Tamagawa M, Nakaya H, Furukawa T. Nontranscriptional regulation of cardiac repolarization currents by testosterone. Circulation 2005;112:1701-10.
75. Zhang Y, Ouyang P, Post WS et al. Sex-steroid hormones and electrocardiographic QT-interval duration: findings from the third National Health and Nutrition Examination Survey and the Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol 2011;174:403-11.
76. Oskui PM, French WJ, Herring MJ, Mayeda GS, Burstein S, Kloner RA. Testosterone and the cardiovascular system: a comprehensive review of the clinical literature. J Am Heart Assoc 2013;2:e000272.